| Cleansing Notice | Nov 19, 2026 | Financing | ASX |
|---|
| Application for quotation of securities - EIQ | Nov 19, 2026 | Financing | ASX |
|---|
| EchoSolv HF regulatory update | Nov 18, 2026 | Legal or regulatory action | ASX |
|---|
| Trading Halt | Nov 18, 2026 | Trading halt or suspension | ASX |
|---|
| Pause in Trading | Nov 18, 2026 | Trading halt or suspension | ASX |
|---|
| Bell Potter Healthcare Conference Presentation | Nov 16, 2026 | Other filings | ASX |
|---|
| Dr Vasum Peiris Appointed as Chief Medical Officer | Nov 15, 2026 | Management or board change | ASX |
|---|
| Notification regarding unquoted securities - EIQ | Nov 4, 2026 | Other filings | ASX |
|---|
| Quarterly Activities Report & Appendix 4C Cashflow Report | Oct 25, 2026 | Quarterly report | ASX |
|---|
| Notice of Annual General Meeting/Proxy Form | Oct 23, 2026 | Meeting notice | ASX |
|---|
| Notification of cessation of securities - EIQ | Oct 22, 2026 | Financing | ASX |
|---|
| EchoSolv HF FDA 510(k) update | Oct 11, 2026 | Operations update | ASX |
|---|
| Date of AGM and Closing Date for Director Nominations | Oct 6, 2026 | Meeting notice | ASX |
|---|
| EchoSolv HF FDA application update | Sep 16, 2026 | Operations update | ASX |
|---|
| Notification regarding unquoted securities - EIQ | Sep 14, 2026 | Other filings | ASX |
|---|
| Cleansing Notice | Sep 10, 2026 | Financing | ASX |
|---|
| Application for quotation of securities - EIQ | Sep 10, 2026 | Financing | ASX |
|---|
| Investor Webinar | Sep 8, 2026 | Other filings | ASX |
|---|
| EchoSolv HF FDA Application Update | Sep 8, 2026 | Operations update | ASX |
|---|
| Trading Halt | Sep 6, 2026 | Trading halt or suspension | ASX |
|---|
| Pause in Trading | Sep 6, 2026 | Trading halt or suspension | ASX |
|---|
| Notification of cessation of securities - EIQ | Sep 4, 2026 | Financing | ASX |
|---|
| S&P DJI Announces September 2026 Quarterly Rebalance | Sep 4, 2026 | Other filings | ASX |
|---|
| Proposed issue of securities - EIQ | Sep 1, 2026 | Financing | ASX |
|---|
| Initial Director's Interest Notice - Scott Wilkin | Sep 1, 2026 | Ownership change notice | ASX |
|---|
| Global healthcare investment leader appointed to Board | Aug 31, 2026 | Management or board change | ASX |
|---|
| Appendix 4G and Corporate Governance Statement | Aug 27, 2026 | Other filings | ASX |
|---|
| Annual Report to Shareholders | Aug 27, 2026 | Annual report | ASX |
|---|
| Preliminary Final Report | Aug 27, 2026 | Results | ASX |
|---|
| Cleansing Notice | Aug 21, 2026 | Financing | ASX |
|---|
| Application for quotation of securities - EIQ | Aug 21, 2026 | Financing | ASX |
|---|
| Convertible note executed with Pro Medicus | Aug 16, 2026 | Financing | ASX |
|---|
| Cleansing Notice | Aug 7, 2026 | Financing | ASX |
|---|
| Application for quotation of securities - EIQ | Aug 7, 2026 | Financing | ASX |
|---|
| Investor Webinar | Jul 27, 2026 | Other filings | ASX |
|---|
| Quarterly Activities Report & Appendix 4C Cashflow Report | Jul 26, 2026 | Quarterly report | ASX |
|---|
| Exclusive Imaging Dataset Strengthens AI Competitive Moat | Jul 1, 2026 | Operations update | ASX |
|---|
| Echo IQ Raises A$110m via Institutional Placement | Jun 30, 2026 | Financing | ASX |
|---|
| Binding HOA secured with Pro Medicus Limited | Jun 24, 2026 | Other filings | ASX |
|---|
| Research collaboration secured with Mayo Clinic | Jun 11, 2026 | Operations update | ASX |
|---|
| $762k R&D Tax Incentive Received | May 25, 2026 | Financing | ASX |
|---|
| QuarterlyActivities Report and Appendix 4C Cash Flow Report | Apr 29, 2026 | Quarterly report | ASX |
|---|
| EchoSolv AS deployed into Mount Sinai Health System | Apr 27, 2026 | Operations update | ASX |
|---|
| Agreement with Mayo Clinic for EchoSolv HF | Mar 23, 2026 | Material contract | ASX |
|---|
| Update - S&P DJI March 2026 Rebalance of the All Ordinaries | Mar 10, 2026 | Other filings | ASX |
|---|
| S&P DJI Announces March 2026 Quarterly Rebalance | Mar 6, 2026 | Other filings | ASX |
|---|
| Appendix 4D 31 December 2025 | Feb 26, 2026 | Interim report | ASX |
|---|
| Quarterly Activities Report and Appendix 4C Cash Flow Report | Jan 23, 2026 | Quarterly report | ASX |
|---|
| Response to ASX Price Query | Jan 22, 2026 | Explanation request | ASX |
|---|
| Formal lodgement of FDA submission for EchoSolv HF | Dec 14, 2025 | Operations update | ASX |
|---|
| Exceptional Results from Validation Study for EchoSolv HF | Nov 23, 2025 | Results | ASX |
|---|
| Quarterly Activities and Appendix 4C Cash Flow Report | Oct 30, 2025 | Quarterly report | ASX |
|---|
| Category III CPT code application update | Oct 6, 2025 | Operations update | ASX |
|---|
| Trading Halt | Oct 5, 2025 | Trading halt or suspension | ASX |
|---|
| Pause in Trading | Oct 5, 2025 | Trading halt or suspension | ASX |
|---|
| Strong Operational Momentum | Oct 2, 2025 | Operations update | ASX |
|---|
| Update on Category III CPT Code Application | Sep 19, 2025 | Operations update | ASX |
|---|
| Preliminary Final Report | Aug 29, 2025 | Results | ASX |
|---|
| Quarterly Activities & Appendix 4C Cashflow Reports | Jul 24, 2025 | Quarterly report | ASX |
|---|
| Reseller Agreement Secured with SARC MedIQ | Jul 10, 2025 | Operations update | ASX |
|---|
| Mayo Clinic Validation Study Underway | Jul 1, 2025 | Operations update | ASX |
|---|
| Echo IQ raises $17.3m via institutional placement | May 7, 2025 | Financing | ASX |
|---|
| Listing on the OTCQB Market | Apr 16, 2025 | Other filings | ASX |
|---|
| Echosolv Collaboration Agreement with Mayo Clinic Platform | Apr 2, 2025 | Operations update | ASX |
|---|
| Expansion Across 36 US Hospitals and Cardiology Practices | Mar 30, 2025 | Operations update | ASX |
|---|
| Investor Webinar Presentation | Mar 6, 2025 | Other filings | ASX |
|---|
| Strong Progress in First Two Months of CY25 Achieved | Mar 4, 2025 | Other filings | ASX |
|---|
| Appendix 4D 31 December 2024 | Feb 27, 2025 | Interim report | ASX |
|---|
| $1.26M R&D TAX INCENTIVE RECEIVED | Feb 12, 2025 | Other filings | ASX |
|---|
| Response to ASX Query Letter | Jan 31, 2025 | Explanation request | ASX |
|---|
| PRE-SUBMISSION MEETING WITH US FDA FOR HEART FAILURE | Dec 23, 2024 | Operations update | ASX |
|---|
| The First Step in EIQs US Market Commercialisation Strategy | Dec 8, 2024 | Operations update | ASX |
|---|
| S&P DJI Announces December 2024 Quarterly Rebalance | Dec 6, 2024 | Other filings | ASX |
|---|
| EIQ signs integration agreement with Flagship US Hospital | Nov 17, 2024 | Other filings | ASX |
|---|
| US Based CEO Appointed to Execute Commercialisation Strategy | Oct 8, 2024 | Management or board change | ASX |
|---|
| Major Milestone Achieved with FDA Clearance for EchoSolv AS | Oct 7, 2024 | Other filings | ASX |
|---|
| Echo IQ Raises $7.1 million | Sep 6, 2024 | Financing | ASX |
|---|
| Groundbreaking study results for Heart Failure AI solution | Sep 3, 2024 | Results | ASX |
|---|
| Strategic Integration Partnership Agreement with ScImage Inc | Jul 4, 2024 | Operations update | ASX |
|---|
| Validation of EIQ AI at Leading Scientific Conference | Jun 5, 2024 | Operations update | ASX |
|---|
| Investor Presentation | May 22, 2024 | Other filings | ASX |
|---|
| Echo IQ Commences New Heart Failure Clinical Study Using AI | May 20, 2024 | Operations update | ASX |
|---|
| US FDA Application Lodged | May 6, 2024 | Operations update | ASX |
|---|
| Quarterly Report | Apr 30, 2024 | Quarterly report | ASX |
|---|
| Appendix 4C Cash Flow Report | Apr 30, 2024 | Quarterly report | ASX |
|---|
| Management Update | Apr 1, 2024 | Management or board change | ASX |
|---|
| Completion of US Reader Study | Mar 27, 2024 | Operations update | ASX |
|---|
| Receipt of Research & Development Tax Incentive | Mar 7, 2024 | Other filings | ASX |
|---|
| Appendix 4D 31 December 2023 | Feb 28, 2024 | Interim report | ASX |
|---|
| RSH: Cardiovascular AI platform integrated into RPM program | Jan 24, 2024 | Other filings | ASX |
|---|
| EIQ Licenses Software to Respiri - Remote Patient Mon. | Jan 24, 2024 | Other filings | ASX |
|---|
| EIQ Appoints Kimber Rothwell as CEO | Jan 15, 2024 | Management or board change | ASX |
|---|
| Business Progress Update | Dec 13, 2023 | Operations update | ASX |
|---|
| Ord Minnett Healthcare Forum | Oct 29, 2023 | Operations update | ASX |
|---|
| Quarterly Activities Report | Oct 24, 2023 | Quarterly report | ASX |
|---|
| EIQ Investor Presentation updated | Oct 15, 2023 | Other filings | ASX |
|---|
| Paid Pilot with Australias Largest Cardiology Provider | Aug 28, 2023 | Other filings | ASX |
|---|
| Significant Expansion of EchoSolv Solutions Suite | Aug 20, 2023 | Other filings | ASX |
|---|
| Echo IQ Advances Global Regulatory Compliance Strategy | Aug 1, 2023 | Other filings | ASX |
|---|
| LAUNCH OF NEW ECHOSOLV SOLUTION FOR MITRAL REGURGITATION | Jul 18, 2023 | Other filings | ASX |
|---|
| ECHO IQ SECURES MAIDEN AUSTRALIAN HOSPITAL SALE OF ECHOSOLV | Jun 21, 2023 | Other filings | ASX |
|---|
| US Cardiovascular Facilities Access EchoSolv via Studycast | Jun 12, 2023 | Other filings | ASX |
|---|
| Echo IQ Delivers on Commercialisation | May 8, 2023 | Other filings | ASX |
|---|
| HYD: Hydrix signs agreement to sell EIQ's EchoSolv platform | May 1, 2023 | Other filings | ASX |
|---|
| Echo IQ Expands Commercial Footprint | May 1, 2023 | Other filings | ASX |
|---|
| Quarterly Activities/Appendix 4C Cash Flow Report | Apr 28, 2023 | Quarterly report | ASX |
|---|
| Flagship Clinical Trial Results At St Vincent Hospitals | Apr 19, 2023 | Other filings | ASX |
|---|
| Appendix 4D 31 December 2022 | Feb 28, 2023 | Interim report | ASX |
|---|
| Amendment to Quarterly Report | Feb 1, 2023 | Quarterly report | ASX |
|---|
| Quarterly Activities/Appendix 4C Cash Flow Report - Dec | Jan 24, 2023 | Quarterly report | ASX |
|---|
| Positive Interim Results From Clinical Trial at St Vincents | Dec 14, 2022 | Interim report | ASX |
|---|
| Echo IQ Launches EchoSolv for Immediate Distribution | Dec 6, 2022 | Other filings | ASX |
|---|
| Echo IQ Announces Positive Results From US Clinical Study | Nov 30, 2022 | Other filings | ASX |
|---|
| Amendment to Appendix 4C | Nov 11, 2022 | Quarterly report | ASX |
|---|
| Quarterly Activities/Appendix 4C Cash Flow Report - Sept | Oct 28, 2022 | Quarterly report | ASX |
|---|
| Reinstatement to Official Quotation | Oct 12, 2022 | Trading halt or suspension | ASX |
|---|
| Echo IQ Selected for HeartX Accelerator & Funding | Oct 11, 2022 | Other filings | ASX |
|---|
| Suspension from Official Quotation | Oct 6, 2022 | Trading halt or suspension | ASX |
|---|
| New Research Presented at Leading Cardiology Conference | Aug 30, 2022 | Other filings | ASX |
|---|
| New Clinical Study with World-Leading US Teaching Hospital | Jul 26, 2022 | Other filings | ASX |
|---|
| Updated Appendix 4C Quarterly Cash Flow Report | Jul 19, 2022 | Quarterly report | ASX |
|---|
| Quarterly Activities/Appendix 4C Cash Flow Report - June | Jul 18, 2022 | Quarterly report | ASX |
|---|
| Presentation of Research Findings Behind Echo IQ Algorithm | Jul 6, 2022 | Other filings | ASX |
|---|
| Sale of Prometheus Information Pty. Limited | May 8, 2022 | Other filings | ASX |
|---|
| Formation of Scientific Advisory Board | Apr 25, 2022 | Other filings | ASX |
|---|
| Quarterly Activities/Appendix 4C Cash Flow Report - March | Apr 12, 2022 | Quarterly report | ASX |
|---|
| Appendix 4D 31 December 2021 | Feb 28, 2022 | Interim report | ASX |
|---|
| STRATEGIC TRANSFORMATION AND NEW AGREEMENT | Oct 19, 2021 | Other filings | ASX |
|---|
| Vesting of Performance Shares | Oct 1, 2021 | Other filings | ASX |
|---|
| ECHOiQ Strategic Partnership | Sep 21, 2021 | Other filings | ASX |
|---|
| ECHOiQ Investor Presentation | Sep 6, 2021 | Other filings | ASX |
|---|
| ECHOiQ Clinical Trial | Sep 5, 2021 | Other filings | ASX |
|---|
| ECHOiQ Six Weeks of Rapid Progress | Jul 14, 2021 | Other filings | ASX |
|---|
| Positive Due Diligence Completed for ECHO IQ Acquisition | May 19, 2021 | Acquisition or disposal | ASX |
|---|
| Quarterly Activities and Cash Flow Report - March 21 | Apr 29, 2021 | Quarterly report | ASX |
|---|
| HWH Two New Innovation Projects in the UK | Apr 28, 2021 | Other filings | ASX |
|---|
| HWH Acquires Specialist AI Company ECHO IQ | Mar 30, 2021 | Acquisition or disposal | ASX |
|---|
| Appendix 3B | Mar 30, 2021 | Financing | ASX |
|---|
| H1 2021 Announcement | Feb 25, 2021 | Other filings | ASX |
|---|
| Appendix 4D 31 December 2020 | Feb 25, 2021 | Interim report | ASX |
|---|
| Houston We Have and Wipro Form a Strategic Alliance | Feb 9, 2021 | Other filings | ASX |
|---|
| Quarterly Activities and Cash Flow Report - December 2020 | Jan 28, 2021 | Quarterly report | ASX |
|---|
| New Client Engagement and Contract Growth | Dec 16, 2020 | Other filings | ASX |
|---|
| Quarterly Activities and Cash Flow Reports - September 2020 | Oct 25, 2020 | Quarterly report | ASX |
|---|
| Appendix 4E & Unaudited Preliminary Financial Statements | Aug 31, 2020 | Results | ASX |
|---|
| Quarterly Activities and Cash Flow Reports - June 2020 | Jul 31, 2020 | Quarterly report | ASX |
|---|
| HWH Confirms $400,000 in Annual Contract Renewals | May 19, 2020 | Other filings | ASX |
|---|
| New Contract Wins Validate Growth Strategy | May 5, 2020 | Material contract | ASX |
|---|
| Quarterly Activities Report and Appendix 4C - March 2020 | Apr 30, 2020 | Quarterly report | ASX |
|---|
| Half Year Results Announcement | Feb 28, 2020 | Interim report | ASX |
|---|
| Appendix 4D and FY20 Interim Financial Report | Feb 28, 2020 | Interim report | ASX |
|---|
| Cleansing Prospectus | Feb 2, 2020 | Offer document | ASX |
|---|
| Quarterly Activities Report and Appendix 4C - December 2019 | Jan 31, 2020 | Quarterly report | ASX |
|---|
| Veriluma Appendix 4C - September 2019 Quarter | Oct 31, 2019 | Quarterly report | ASX |
|---|
| Veriluma Quarterly Activities Report - September 2019 | Oct 30, 2019 | Quarterly report | ASX |
|---|
| Department of Defence Appoints VRI for Additional Services | Oct 7, 2019 | Other filings | ASX |
|---|
| Strategic Acquisition of Prometheus | Oct 6, 2019 | Acquisition or disposal | ASX |
|---|
| Veriluma Closes Over-Subscribed Capital Raising | Sep 3, 2019 | Financing | ASX |
|---|
| Supplementary Prospectus | Sep 1, 2019 | Offer document | ASX |
|---|
| Appendix 4E - Preliminary Final Report (30 June 2019) | Aug 30, 2019 | Results | ASX |
|---|
| Prospectus | Jul 28, 2019 | Offer document | ASX |
|---|
| Appendix 4C - June 2019 Quarter (Replacement) | Jul 26, 2019 | Quarterly report | ASX |
|---|
| Appendix 4C - June 2019 Quarter | Jul 24, 2019 | Quarterly report | ASX |
|---|
| Notice of Annual General Meeting and Proxy Form | Jul 8, 2019 | Meeting notice | ASX |
|---|
| Receipt of Funds | Jul 4, 2019 | Other filings | ASX |
|---|
| June 18 Quarterly Activities Report and App 4C | May 17, 2019 | Quarterly report | ASX |
|---|
| Mar 18 Quarterly Activities Report and App 4C | May 16, 2019 | Quarterly report | ASX |
|---|
| Dec 17 Quarterly Activities Report and App 4C | May 16, 2019 | Quarterly report | ASX |
|---|
| HYE Dec 18 App 4D and Interim Financial Report | May 16, 2019 | Interim report | ASX |
|---|
| FYE June 2018 App 4E and Annual Report | May 16, 2019 | Annual report | ASX |
|---|
| HYE Dec 17 App 4D and Interim Financial Report | May 16, 2019 | Interim report | ASX |
|---|
| March 2019 Quarterly Activities and Appendix 4C | Apr 30, 2019 | Quarterly report | ASX |
|---|
| Veriluma and MITN Partnership | Feb 24, 2019 | Other filings | ASX |
|---|
| VRI to commence Department of Defence Contract | Feb 21, 2019 | Other filings | ASX |
|---|
| December 2018 Quarterly Activities and Appendix 4C | Jan 31, 2019 | Quarterly report | ASX |
|---|
| September 2018 Quarterly Activities and Appendix 4C | Jan 31, 2019 | Quarterly report | ASX |
|---|
| Suspension from Official Quotation - Annual Listing Fees | Aug 22, 2018 | Trading halt or suspension | ASX |
|---|
| Veriluma to acquire Concept Safety Systems | Sep 20, 2017 | Acquisition or disposal | ASX |
|---|
| Appendix 4E | Aug 31, 2017 | Results | ASX |
|---|
| Quarterly Activities Report and Appendix 4C | Jul 28, 2017 | Quarterly report | ASX |
|---|
| Veriluma Completes Sale of Mining Asset | Jul 24, 2017 | Other filings | ASX |
|---|
| VRI Partners with US-based Diamond Capture Associates | Apr 26, 2017 | Other filings | ASX |
|---|
| VRI Boosts Cash Balance with Sale of Mining Assets | Apr 20, 2017 | Other filings | ASX |
|---|
| Appendix 4D | Feb 28, 2017 | Interim report | ASX |
|---|
| Leading Law Firm to Trial VRIs Prescriptive Analytics | Feb 13, 2017 | Other filings | ASX |
|---|
| Update on Contract with Departmenrt of Defence | Dec 22, 2016 | Other filings | ASX |
|---|
| VRI Secures Contract with Australian Department of Defence | Dec 18, 2016 | Other filings | ASX |
|---|
| Appendix 4C - quarterly | Oct 30, 2016 | Quarterly report | ASX |
|---|
| Reinstatement to Official Quotation (27/09/2016) | Oct 6, 2016 | Trading halt or suspension | ASX |
|---|
| Suspenion from Official Quotation | Jul 12, 2016 | Other filings | ASX |
|---|
| Transaction Update | May 10, 2016 | Other filings | ASX |
|---|
| Quarterly Activities Report and Quarterly Cashflow Report | Apr 28, 2016 | Quarterly report | ASX |
|---|
| Veriluma Secures Commercial Agreement with RPMG | Apr 20, 2016 | Other filings | ASX |
|---|
| Veriluma Enters Strategic Partnership with Global Business | Apr 3, 2016 | Other filings | ASX |
|---|
| Parmelia Closes Over-Subscribed $1.1M Capital Raising | Mar 30, 2016 | Financing | ASX |
|---|
| MOA to Acquire Boston Gold Project in Philippines | Mar 30, 2016 | Acquisition or disposal | ASX |
|---|
| Results of Phase 1 Scout Drilling at Darvii Naruu, Mongolia | Mar 30, 2016 | Operations update | ASX |
|---|
| Placement | Mar 30, 2016 | Financing | ASX |
|---|
| Survey commences at Darvii Naruu Cu-Au project, Mongolia | Mar 30, 2016 | Other filings | ASX |
|---|
| Agreement signed to acquire Mongolian Copper Gold project | Mar 30, 2016 | Acquisition or disposal | ASX |
|---|